|
Video: What is a Stock Split?
|
|
Fulgent Genetics is a holding company. Through its subsidiaries, Co. is a technology company providing COVID-19 testing services, molecular diagnostic testing services and genetic testing designed to provide physicians and patients with clinically actionable diagnostic information to improve the quality of patient care. Co. has developed a proprietary technology platform allowing Co. to provide a test menu. Combining next generation sequencing with its technology platform, Co. performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels that can be tailored to meet customer needs. According to our Fulgent Genetics stock split history records, Fulgent Genetics has had 0 splits. | |
|
Fulgent Genetics (FLGT) has 0 splits in our Fulgent Genetics stock split history database.
Looking at the Fulgent Genetics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Fulgent Genetics shares, starting with a $10,000 purchase of FLGT, presented on a split-history-adjusted basis factoring in the complete Fulgent Genetics stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/30/2016 |
|
End date: |
05/06/2024 |
|
Start price/share: |
$9.22 |
|
End price/share: |
$21.49 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
133.08% |
|
Average Annual Total Return: |
11.77% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$23,302.60 |
|
Years: |
7.60 |
|
|
|
|
|